Metabolic effects of fluvastatin extended release 80 mg and atorvastatin 20 mg in patients with type 2 diabetes mellitus and low serum high-density lipoprotein cholesterol levels: a 4-month, prospective, open-label, randomized, blinded-end point (pr
about
Metabolic effects of fluvastatin extended release 80 mg and atorvastatin 20 mg in patients with type 2 diabetes mellitus and low serum high-density lipoprotein cholesterol levels: a 4-month, prospective, open-label, randomized, blinded-end point (pr
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabolic effects of fluvastat ...... domized, blinded-end point (pr
@en
Metabolic effects of fluvastat ...... domized, blinded-end point (pr
@nl
type
label
Metabolic effects of fluvastat ...... domized, blinded-end point (pr
@en
Metabolic effects of fluvastat ...... domized, blinded-end point (pr
@nl
prefLabel
Metabolic effects of fluvastat ...... domized, blinded-end point (pr
@en
Metabolic effects of fluvastat ...... domized, blinded-end point (pr
@nl
P2093
P2860
P921
P1476
Metabolic effects of fluvastat ...... linded-end point (probe) trial
@en
P2093
Barbara Guazzini
Enrica Chebat
Maurizio Bevilacqua
Rosanna Toscano
Velella Righini
P2860
P304
P356
10.1016/J.CURTHERES.2004.06.004
P50
P577
2004-07-01T00:00:00Z